Medicine and Dentistry
Brain Metastasis
100%
Stereotactic Radiosurgery
67%
Randomized Controlled Trial
53%
Observational Study
42%
Cohort Analysis
42%
Neoplasm
41%
Retrospective Cohort Study
39%
Maturity Onset Diabetes of the Young
34%
Hazard Ratio
34%
Patient with Type 2 Diabetes
32%
Gamma Knife Radiosurgery
29%
Silo-Filler's Disease
28%
Aortic Dissection
28%
Lung Cancer
27%
Disease
26%
Tofogliflozin
26%
Hemoglobin A1c
25%
Overall Survival
25%
Quality of Life
25%
Adverse Event
25%
COVID-19
24%
Cross Sectional Study
24%
Breast Cancer
24%
Mycobacterium Avium Complex
23%
Congenital Diaphragm Hernia
23%
Surgical Infection
23%
Cardiovascular Disease
20%
Diabetes
20%
Obstructive Sleep Apnea
19%
Symptom
19%
Odds Ratio
18%
Sitagliptin
18%
Olanexidine
18%
Malignant Neoplasm
18%
Elderly Patient
18%
Breathing
17%
Clinical Trial
17%
Body Mass Index
17%
Combination Therapy
17%
Group Therapy
17%
Placebo
16%
Prognostic Factor
15%
General Anesthesia
15%
Prospective Study
15%
Prognostic Assessment
14%
Non Small Cell Lung Cancer
14%
Atherosclerosis
14%
Diseases
14%
Carotid Atherosclerosis
14%
Stomach Cancer
14%
Pharmacology, Toxicology and Pharmaceutical Science
Brain Metastasis
84%
Cohort Study
78%
Non Insulin Dependent Diabetes Mellitus
46%
Disease
44%
Clinical Trial
37%
Coronavirinae
32%
Neoplasm
27%
Randomized Controlled Trial
26%
Overall Survival
26%
Tofogliflozin
26%
Biological Marker
25%
Heart Failure
25%
Sitagliptin
24%
Chronic Obstructive Lung Disease
24%
Adverse Event
22%
Cardiovascular Disease
21%
Chemotherapy
19%
Diseases
19%
Syndrome
18%
Observational Study
18%
Disease Exacerbation
17%
Median Survival Time
16%
Hemoglobin A1c
16%
Metformin
15%
Lung Disease
15%
Diabetes Mellitus
15%
Polyneuropathy
15%
Symptom
14%
M Protein
14%
Chronic Thromboembolic Pulmonary Hypertension
14%
Ipragliflozin
14%
Endocrine Disease
14%
Congenital Diaphragm Hernia
14%
Hemodialysis
14%
Rheumatoid Arthritis
14%
Clinical Feature
13%
Vasculotropin
13%
Placebo
12%
Atherosclerosis
12%
Mycobacterium Avium Complex
11%
Prospective Cohort Study
11%
Progression Free Survival
10%
Non Small Cell Lung Cancer
10%
Malignant Neoplasm
10%
Prospective Study
10%
Cardiovascular Risk
10%
Methotrexate
9%
Uric Acid
9%
Topiroxostat
9%
Thalidomide
9%
Keyphrases
Brain Metastases
66%
Japan
55%
Stereotactic Radiosurgery
50%
Confidence Interval
38%
COVID-19
33%
Tumor
27%
Non-small Cell Lung Cancer (NSCLC)
19%
Multi-institutional
18%
Long COVID
18%
Prospective Observational Study
18%
Hazard Ratio
17%
Odds Ratio
17%
Gamma Knife Radiosurgery
17%
Japanese Patients
17%
Type 2 Diabetes Mellitus (T2DM)
16%
Type 2 Diabetic Patients
16%
Graded Prognostic Assessment
14%
Chronic Obstructive Pulmonary Disease
14%
Body Mass Index
14%
Utopia
14%
Retrospective Cohort Study
13%
Risk Factors
13%
Overall Survival
12%
Median Survival Time
12%
Multicenter Cohort Study
12%
Small Cell Lung Cancer
12%
Prognostic Factors
11%
Aortic Events
11%
Surgical Site Infection
11%
Radiosurgery Alone
11%
Treatment Results
11%
Elderly Patients
11%
Surgical Outcomes
10%
Nationwide Survey
10%
Propensity Score Analysis
10%
Long Coronavirus Disease
10%
Organ Space Surgical Site Infection
9%
Clinical Characteristics
9%
Sitagliptin
9%
St. George's Respiratory Questionnaire
9%
Graded-index
9%
Renal Progenitor
9%
Anxiety Prevention
9%
Non-inferiority Trial
9%
Type B Aortic Dissection
9%
Tofogliflozin
9%
Renal Cancer
9%
Brain Metastasis Velocity
9%
Validation Studies
9%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
9%